Lauren S. Schlesselman, PharmD, and Christopher Konecny
CASEONE:
JT is a 5-year-old boy who
was brought to the children's
hospital emergency department
by his parents after spiking
a fever of 102.1°F overnight.
JT's mother also informs
the doctors that JT has had
poor food intake since his last
chemotherapy. This past week,
JT was treated with vincristine, high-dose cyclophosphamide,
and etoposide. This cycle was week 14 of 54 of the inductionphase
chemotherapy for acute lymphoblastic leukemia. JT
receives chemotherapy every other week in the hospital's outpatient
clinic.
On this admission, the doctor obtained both a blood culture
and complete blood count. The complete blood count for the
patient showed a white blood count of 1.6, hemoglobin of 9.3,
hematocrit 24.6, and platelets 80,000. On physical exam, the
patient has grade II mucositis in the mouth. The patient was
started on acetaminophen every 4 to 6 hours as needed for
fever, vancomycin every 8 hours, and cefepime every 8 hours.
The doctor admits JT to pediatric oncology. While waiting
for the results of the blood cultures, JT continues to spike a
fever. When the pharmacist is reviewing JT's chart, she is concerned
by the continued temperature spikes. She decides to
discuss the issue during the oncology multidisciplinary
rounds. She would like to broaden JT's antibiotic coverage.
What bacterial species should the pharmacist cover for?
What antibiotic should the pharmacist recommend adding to
the regimen to cover this species?
CASETWO:
Despite adding gentamicin
to his antibiotic therapy, JT is
still spiking fevers after 5 days
of treatment. On the preliminary
results, the blood cultures
did not grow any bacteria.
During morning rounds,
the attending physician asks
the medical student what he would recommend. Because the
medical student does not have an answer, the attending
physician instructs him to look it up after rounds and page him
when he has an answer. Immediately following rounds, the
medical student approaches the pharmacist and asks for help.
The pharmacist reminds the medical student that JT is
receiving coverage for gram-positive and gram-negative bacteria.
In an attempt to encourage the medical student to think
through the answer, she asks the student what is not being
covered by the current regimen. Suddenly experiencing an
epiphany, the medical student realizes that the current antibiotic
therapy does not cover for yeast.
What additional antimicrobial coverage should the medical
student recommend?
CASETHREE:
Following discharge, JT
returns to the oncology clinic
for another round of chemotherapy
with vincristine, high
dose cyclophosphamide, and
etoposide. The physician who
normally treats JT is on vacation,
so a covering physician is
assigned to his case. He asks the pharmacist for assistance
since she knows JT's case. Due to the high emetic potential of
JT's regimen, the physician inquires if JT received antiemetic
therapy. The pharmacist confirms that JT did receive antiemetics.
She also informs him that JT suffers from anticipatory nausea
and vomiting. The physician asks the pharmacist to recommend
medications for both.
What medications should the pharmacist recommend?
Dr. Schlesselman is an assistant clinical professor at the University of Connecticut School of
Pharmacy. Mr. Konecny is a
PharmD candidate at the University of Connecticut School of Pharmacy.
| Click Here For The Answer -----------> |
[-] |
CASE ONE: Despite antibiotic therapy, JT continues to spike fevers, prompting the pharmacist to
consider other bacterial causes. In
particular, the pharmacist should consider providing coverage for Pseudomonas aeruginosa. To
extend the antibiotic coverage to better cover for
Pseudomonas, the pharmacist recommends adding gentamicin 2 to 2.5 mg/kg/dose every 8 hours.
Gentamicin will produce synergy with other antibiotics
against Pseudomonas. The pharmacist should also recommend obtaining peak levels to assess for
efficacy and trough levels to assess for toxicity
after 3 doses.
CASE TWO: To cover for yeast, in particular Candida species, the medical student should
recommend adding fluconazole to the therapy. The recommended
dose is 10 to 12 mg/kg/day with a maximum dose of 600 mg/day.
CASE THREE: According to the American Society of Clinical Oncology, the high emetic potential of
JT's regimen warrants treatment with a 5-HT3 serotonin
receptor antagonist on day 1, preferably around the clock, in combination with dexamethasone and
aprepitant on days 1, 2, and 3. The pharmacist
also recommends lorazepam for JT's anticipatory nausea and vomiting.